- 081MarketSource · Medical Device Network
4DMedical and Azra AI join forces to advance lung care pathways
4DMedical and Azra AI have formed a partnership to provide integrated lung care management solutions for health institutions. The collaboration combines 4DMedical's imaging technology with Azra AI's diagnostic software to enable end-to-end lung disease detection and monitoring across clinical workflows.
- 082MarketSource · Medical Device Network
Olympus strikes global distribution agreement for Endocision’s cryocatheter
Olympus has signed a global distribution agreement for Endocision's cryocatheter, with commercial launch planned in the US, Canada, and Europe starting in early 2027. The deal expands Olympus's portfolio in minimally invasive surgical tools and represents a significant partnership in the cryotherapy device space.
- 083MarketSource · Medical Design & Outsourcing
Zeus plans new catheter manufacturing facility in Costa Rica
Zeus has leased a new catheter manufacturing facility for its CathX Medical subsidiary in Costa Rica's La Lima Free Zone. The expansion supports long-term customer demand as programs transition from development to commercialization, according to CEO Paddy O'Brien.
- 084MarketSource · Medical Device Network
Bridge to Life raises $110m to advance liver perfusion system’s rollout
Bridge to Life secured $110 million in funding to support US commercialization of its VitaSmart liver perfusion system, expand its product portfolio, and scale global operations. The capital will accelerate market entry and broader international deployment of the organ perfusion technology.
- 085MarketSource · Medical Device Network
Abbott and Google Health partner for glucose monitoring solutions
Abbott and Google Health announced a partnership to integrate continuous glucose monitoring with AI-driven health guidance within Google Health's platform. The collaboration combines Abbott's monitoring hardware with Google's software and AI capabilities to deliver glucose data and personalized insights to users.
- 086MarketSource · Medical Device Network
Alcon raises 2026 earnings growth outlook on positive Q2 results
Alcon reported strong Q2 results and raised its 2026 earnings growth outlook. The surgical segment generated approximately $1.6 billion in revenue, representing 8% year-over-year growth and accounting for the largest share of company profits.
- 087MarketSource · Medical Device Network
Teledyne agrees to acquire Varex Imaging for $1.1bn
Teledyne Technologies agreed to acquire Varex Imaging for approximately $1.1 billion in an all-cash transaction. Varex, a supplier of X-ray imaging components and subsystems used in medical, industrial, and security applications, becomes part of Teledyne's portfolio. The deal expands Teledyne's presence in medical imaging technology and component supply.
- 088MarketSource · Medical Device Network
Resmed’s stock falls by 7% on soft FY27 outlook
ResMed's stock declined 7% following the company's cautious FY27 guidance. The manufacturer cited suspended ventilator sales and macroeconomic uncertainty as headwinds affecting its outlook. The ventilator suspension signals potential supply-chain or regulatory constraints impacting a key product line.
- 089MarketSource · MedCity News
Two Differing POVs Emerge About the Hinge-Cylinder Deal
Hinge Health acquired Cylinder to expand into gastrointestinal care offerings. The deal represents a strategic move into a new clinical domain, though industry observers are divided on whether employers will prioritize the convenience of an integrated platform over specialized standalone solutions for GI diagnostics and treatment.
- 090MarketSource · Medical Device Network
iRhythm advances cardiac monitoring provision with $287.5m VitalConnect acquisition
iRhythm Technologies acquired VitalConnect for $287.5 million, expanding its cardiac monitoring portfolio. The deal was announced alongside iRhythm's Q2 results, which showed revenue growth of 20.1% year-over-year. VitalConnect's wearable monitoring technology complements iRhythm's existing cardiac diagnostic capabilities.
- 091MarketSource · Medical Device Network
Philips broadens patient monitoring capabilities with six new partnerships
Philips announced six new partnerships aimed at expanding its patient monitoring ecosystem, particularly for out-of-hospital monitoring capabilities. The partnerships are designed to broaden Philips' reach and integration options in remote patient monitoring and connected care delivery.
- 092MarketSource · Medical Device Network
Azra AI and Blackford partner to connect imaging AI with care coordination
Azra AI and Blackford announced a partnership to integrate imaging-based AI detection with care coordination workflows for patients with complex or urgent conditions. The partnership aims to bridge diagnostic imaging AI output with downstream clinical care management systems, enabling better handoff and coordination between detection and treatment planning.
- 093MarketSource · Medical Device Network
Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook
Zimmer Biomet reported 4.8% year-over-year revenue growth in Q2 and raised its 2026 financial outlook, driving a 5% share price increase at NYSE opening on August 5. The earnings beat reflects demand across the company's orthopedics, spine, and specialty surgical portfolios.
- 094MarketSource · Medical Device Network
Wellinks secures $10m for respiratory disease RPM tool’s advancement
Wellinks raised $10 million in Series B funding to advance its remote patient monitoring platform for respiratory disease management. The round included participation from UMass Memorial Health, building on an existing relationship. The funding will support continued development of the RPM tool for chronic respiratory conditions.
- 095MarketSource · Medical Device Network
SMT adopts Siemens software for device innovation
SMT has implemented Siemens' Teamcenter software to accelerate medical device innovation and manage product lifecycles across the organization. The deployment reflects a vendor's investment in digital infrastructure to improve R&D efficiency and time-to-market for device development.
- 096MarketSource · Medical Device Network
SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics
SOPHiA GENETICS and AstraZeneca announced a partnership to co-develop and launch two companion diagnostics for precision oncology therapies. The collaboration combines SOPHiA's diagnostic software platform with AstraZeneca's oncology drug portfolio, positioning both firms to expand their presence in the companion diagnostics market.
- 097MarketSource · Medical Device Network
KKR to acquire Integer Holdings in $5.7bn all-cash deal
KKR has agreed to acquire Integer Holdings in an all-cash transaction valued at $5.7 billion. Integer Holdings is a supplier of medical devices and components to the healthcare industry, making this a significant consolidation in the medical equipment and supplies vendor landscape.
- 098MarketSource · Medical Device Network
Profusa vies for potential G3 Vision Labs acquisition
Profusa is pursuing a potential acquisition of G3 Vision Labs to expand its diagnostic portfolio with routine chemistry, toxicology, and pathology offerings. The deal would add laboratory diagnostic capabilities to Profusa's existing product lines.
- 099MarketSource · Medical Device Network
CereVasc expands manufacturing with Wilmington facility for eShunt system
CereVasc opened a manufacturing and research facility in Wilmington, Massachusetts to support potential commercialization of its eShunt System, an investigational device for hydrocephalus management. The expansion signals preparation for market entry as the company advances toward regulatory pathways.
- 100MarketSource · Medical Design & Outsourcing
Quasar Medical buys Medres Nitinol Design and Development Center
Quasar Medical, a contract development and manufacturing organization specializing in minimally invasive devices, has acquired Medres' Nitinol Design and Development Center near San Diego. The 10,000-square-foot Carlsbad facility, established in 2024 and expanded in 2025, brings dedicated nitinol engineering talent and manufacturing capabilities to Quasar's operations.
- 101MarketSource · Medical Device Network
Dexcom tweaks full-year outlook after reporting 13% growth in Q2
Dexcom reported 13% revenue growth in Q2 and adjusted its full-year outlook upward following the earnings release on July 30. The company's Nasdaq shares rose over 8% to $81.04 at market open July 31, reflecting investor confidence in the revised guidance.
- 102MarketSource · Medical Device Network
Stryker nets $6.6bn revenue in Q2; highlights resilience following cyberattack
Stryker reported $6.6 billion in Q2 revenue following a March 2026 cyberattack that disrupted global operations. The earnings result demonstrates the company's operational resilience despite the security incident and its recovery efforts.
- 103MarketSource · MedCity News
Why General Catalyst Is Betting $450M on Function Health’s Preventive Care Push
Function Health, a lab-testing and imaging services startup, raised $450 million in growth financing from General Catalyst's Customer Value Fund, eight months after closing a $298 million Series B round. The company plans to use the capital to expand access to its testing and imaging service offerings.
- 104MarketSource · Medical Device Network
Median Technologies and Olea sign partnership for lung cancer device
Median Technologies partnered with Olea Medical to commercialize eyonis LCS, a lung cancer screening software, across the US and European markets. The collaboration expands distribution capabilities for the AI-enabled diagnostic tool designed to support lung nodule analysis in imaging workflows.
- 105MarketSource · Medical Device Network
Baxter’s shares soar by 17% after reporting positive Q2
Baxter International reported a 5% profit increase in Q2 compared to the same period last year, when results were depressed by hurricane damage to a North Carolina manufacturing facility. The earnings announcement drove a 17% surge in the company's stock price.
- 106MarketSource · Medical Device Network
CoreMap raises $37m in Medtronic-led financing round
CoreMap, a privately held medical device company founded in 2016, raised $37 million in a financing round led by Medtronic. The funding nearly doubles the company's total capital raised to date. No additional details on CoreMap's product focus or intended use of proceeds were provided.
- 107MarketSource · Medical Device Network
Trace secures funding from Axogen for nerve imaging technology
Trace Biosciences received strategic funding from Axogen to develop Nerve Trace, a nerve-specific imaging technology. The investment supports advancement of the imaging platform, which targets nerve visualization applications relevant to surgical and diagnostic workflows.
- 108MarketSource · MedCity News
Doctronic Acquires Summer Health to Expand into Pediatric Primary Care
Doctronic acquired Summer Health to expand its AI-powered primary care platform into pediatric care. The deal strengthens Doctronic's digital health offerings and extends its reach into the pediatric primary care segment.
- 109MarketSource · MedCity News
Epic-First Doesn’t Mean Epic-Only: Where Hospitals Are Still Buying from Startups
A survey of 112 health system executives shows Epic's dominance in hospital IT continues to grow, yet startups retain purchasing opportunities by addressing gaps Epic has not filled, delivering measurable ROI, or solving specific clinical or operational problems. The findings suggest a tiered procurement model where health systems prioritize Epic integration but remain open to best-of-breed vendors that complement rather than replace their core platform.
- 110MarketSource · Medical Device Network
Boston Scientific reports positive Q2 results yet opts to trim 2026 outlook
Boston Scientific reported positive second-quarter financial results but reduced its 2026 outlook, citing planned global restructuring efforts. The company's earnings beat expectations, though the forward guidance cut reflects anticipated impacts from the reorganization program on future performance and operations.
- 111MarketSource · MedCity News
Smart Toilet Sensor Startup Is Flush with $10M Funding
Throne Science, a startup developing an AI-powered toilet sensor for monitoring gut health, hydration, and urinary function, closed a $10 million Series A funding round. The company positions the device as an early-warning system for colorectal cancer and other gastrointestinal conditions, addressing a gap in home health monitoring.
- 112MarketSource · Medical Device Network
Boston Scientific expects headcount reductions amid restructuring initiative
Boston Scientific announced a restructuring initiative expected to result in headcount reductions, with total costs estimated between $700 million and $800 million through the end of 2029. The company did not disclose the specific number of positions affected or operational details in the announcement.
- 113MarketSource · Medical Device Network
Xeltis sharpens US market roadmap after €20.5m fundraise
Xeltis raised €20.5 million in funding to refine its US market strategy, following a €47.5 million round completed in December 2025. The Swiss biotech company, which develops bioresorbable scaffolds and regenerative medical devices, is using the capital to accelerate commercialization efforts in North America.
- 114MarketSource · Medical Device Network
Nuwellis’ new CEO on building a strong foundation for sustainable value creation
Mike McCormick assumed the role of CEO at Nuwellis on 30 June, tasked with building on the company's positive Q1 2026 financial results. Nuwellis manufactures renal replacement therapy and fluid management devices for critical care settings. The leadership transition marks a shift in company strategy as McCormick focuses on sustainable value creation and operational foundation-building.
- 115MarketSource · Medical Device Network
Magnendo raises $18m to advance robotic platform
Magnendo closed an $18 million Series A funding round to advance its magnetic robotic navigation platform for neuro-endovascular procedures. The capital will support further development of the technology, which targets minimally invasive vascular interventions in neurology.
- 116MarketSource · Medical Device Network
Medtronic continues assembly of industry’s “broadest” pain therapy portfolio
Medtronic completed its $650 million acquisition of SPR Therapeutics and formally launched ViaVerte at the American Society of Pain Neuromodulation conference on 16 July. The deal expands Medtronic's pain management portfolio, adding peripheral nerve stimulation technology to its existing spinal cord stimulation and neuromodulation offerings.
- 117MarketSource · Medical Device Network
Edwards lifts FY26 growth outlook following steady Q2 performance
Edwards Lifesciences raised its full-year 2026 revenue growth guidance following solid second-quarter results, driven primarily by its transcatheter aortic valve replacement (TAVR) business, which generated $1.26 billion in Q2 revenues. The company's strong TAVR performance underpinned confidence in its revised outlook.
- 118MarketSource · Medical Device Network
bioAffinity and Pictor partner on diagnostics for asthma and COPD
bioAffinity Technologies partnered with Pictor to develop and commercialize diagnostic tests for asthma and chronic obstructive pulmonary disease (COPD). The collaboration combines the companies' capabilities to advance respiratory disease diagnostics, though specific product timelines and technical details were not disclosed.
- 119MarketSource · Medical Design & Outsourcing
Arterex Tecate opens ISO Class 8 clean room facility
Arterex Tecate, a medical device contract manufacturer, opened a 9,000-square-foot ISO Class 8 clean room facility. The expansion increases manufacturing capacity for medical devices and demonstrates the company's investment in quality and regulatory compliance infrastructure.
- 120MarketSource · Medical Device Network
TYBR Health lands $30m to advance orthopaedic hydrogel platform
TYBR Health secured $30 million in funding to expand market access for its B3 GEL orthopaedic hydrogel, which launched in the US in January 2026. The company plans to use the capital primarily to grow distribution and market penetration of the platform.